Innorna
PrivateLast Round
Series B
Mar 28, 2022
Total Funding Raised
$120M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Innorna is a biotechnology company that develops mRNA-based medicines and proprietary lipid nanoparticle (LNP) delivery systems to treat chronic diseases, power in vivo immunotherapies, and prevent infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Innorna Comparables
Compare Innorna with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Immorna Biotherapeutics | 89% | |
| Immorna | 88% | |
| RVAC Medicines | 88% | |
Innorna Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 28, 2022 | ||||
| Series A | Jul 22, 2021 | ||||
| Angel | Nov 1, 2020 |
Innorna Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Optimas Capital | Series B |
| Huasheng Capital | Series B |
| Legend Capital | Series A |
| CITIC Private Equity Funds Management | Series B |
| YF Capital | Series B |
| Fangyuan Capital (Hong Kong) Limited | Series B |
| CAS Star | Series A, Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 137% MoM, reaching 1K.
- Jul 13, 2026
Open roles increased to 7, 58% of headcount.
Innorna Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Innorna's valuation, stock price, and market status.